Screening and Model Systems for Therapies of Alzheimer Disease (AD)
A new strategy for the therapy of AD describes that moderate enhancement of the α-secretase ADAM10 completely inhibits amyloid plaque deposition and enhances the production of the N-terminal domain of the amyloid precursor protein (APP), that acts as neuropotective component. As a consequence, these effects improve synaptic plasticity and reduces cognitive defects shown in a transgenic mouse model for AD.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-0
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Recovering phosphorus from sewage sludge ash
Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…